Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 04 04:00PM ET
2.16
Dollar change
-0.06
Percentage change
-2.87
%
Index- P/E4.27 EPS (ttm)0.51 Insider Own83.03% Shs Outstand112.82M Perf Week-3.09%
Market Cap243.83M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float19.15M Perf Month18.10%
Income52.20M PEG- EPS next Q- Inst Own0.22% Short Float0.09% Perf Quarter-13.90%
Sales414.10M P/S0.59 EPS this Y- Inst Trans15.44% Short Ratio2.97 Perf Half Y-30.40%
Book/sh0.35 P/B6.18 EPS next Y- ROA10.77% Short Interest0.02M Perf Year-39.80%
Cash/sh0.16 P/C13.89 EPS next 5Y- ROE350.21% 52W Range1.68 - 4.95 Perf YTD-46.90%
Dividend Est.- P/FCF11.94 EPS past 5Y- ROI20.07% 52W High-56.34% Beta0.15
Dividend TTM- Quick Ratio0.99 Sales past 5Y- Gross Margin55.04% 52W Low28.64% ATR (14)0.13
Dividend Ex-Date- Current Ratio1.47 EPS Y/Y TTM134.82% Oper. Margin8.15% RSI (14)55.24 Volatility1.39% 6.79%
Employees- Debt/Eq7.36 Sales Y/Y TTM-4.80% Profit Margin12.61% Recom3.00 Target Price4.50
Option/ShortNo / Yes LT Debt/Eq5.60 EPS Q/Q-63.68% Payout- Rel Volume0.22 Prev Close2.22
Sales Surprise6.88% EPS Surprise0.00% Sales Q/Q7.25% Earnings- Avg Volume6.08K Price2.16
SMA208.43% SMA503.66% SMA200-24.10% Trades Volume1,329 Change-2.87%
Sep-18-24 08:10AM
Sep-03-24 09:10AM
Jul-01-24 02:18PM
Jun-28-24 08:31AM
May-20-24 04:05PM
04:10PM Loading…
May-14-24 04:10PM
May-01-24 04:10PM
Mar-04-24 08:00AM
Feb-05-24 08:50AM
Jan-16-24 08:50AM
Dec-26-23 05:40PM
Dec-21-23 06:45PM
Nov-29-23 07:54PM
Nov-22-23 08:30AM
Nov-14-23 05:25PM
11:37AM Loading…
Nov-10-23 11:37AM
Oct-30-23 08:30AM
Oct-23-23 05:01PM
Oct-16-23 08:31AM
Oct-02-23 08:00AM
Sep-15-23 08:20AM
Sep-07-23 08:30AM
Sep-05-23 08:25AM
Aug-31-23 06:35PM
Aug-16-23 08:31AM
Jun-05-23 07:45PM
May-12-23 05:30PM
May-01-23 08:17AM
Feb-13-23 04:36PM
Jan-19-23 04:32PM
04:13PM Loading…
Jan-03-23 04:13PM
Dec-29-22 08:00AM
Dec-22-22 04:02PM
Nov-14-22 05:32PM
Nov-08-22 03:36PM
Oct-11-22 08:00AM
Oct-05-22 10:15AM
Aug-30-22 06:40AM
Aug-15-22 06:25AM
Jun-26-22 08:33AM
Jun-02-22 08:14AM
May-22-22 10:31AM
May-17-22 04:44PM
Apr-29-22 09:12PM
Apr-22-22 08:20AM
Mar-08-22 04:38AM
Feb-08-22 01:38PM
Feb-02-22 08:31AM
Jan-28-22 09:26AM
Jan-12-22 08:31AM
Nov-29-21 07:58AM
Nov-19-21 08:41AM
Procaps Group SA is an international healthcare and pharmaceutical company. The firm is engaged in the developing of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It operates through the following segments: NextGel, Procaps Colombia, CAN, CASAND, and Diabetrics. The NextGel segment is involved in the manufacturing and distribution of prescription and over-the-counter pharmaceutical products in USA, Brazil, and Colombia. The Procaps Colombia segment is focused on the manufacturing and distribution of prescription and over-the-counter pharmaceutical products in Colombia. The CAN segment deals with the manufacturing and distribution of prescription and over-the-counter pharmaceutical products in Northern Central America: Salvador, Guatemala, Nicaragua, and Honduras. The CASAND segment offers pharmaceutical products in Southern Central America that include Panama and Costa Rica, and the North Andes District that include Ecuador, Peru, and Bolivia. The Diabetrics segment consists of the diabetes solutions and chronic disease management tool. The company was founded by Ruben Minski in 1977 and is headquartered in Luxembourg.